SFEBES2018 Poster Presentations Neuroendocrinology and pituitary (25 abstracts)
Christian Medical College, Vellore, India.
Objective: To study the metabolic profile of patients after surgery for pituitary tumors.
Methods: This retrospective study included 1138 patients from 2000 to 2017. Those with prolactinomas, pituitary apoplexy and surgery elsewhere were excluded. The analysis included 525 patients, non-functional tumors (143), acromegaly (267), Cushings disease (113) and TSHoma (1). The patients blood pressure, blood sugar, lipid profile and body mass index (BMI) was serially followed up. The median duration of follow up was 2.6 years (range 114 years). The follow up included nonfunctional tumors (71) and patients in remission acromegaly (106), Cushings disease (70) and TSHomas (1).
Results: At diagnosis 51, 68 & 79% of patients respectively with non-functional tumors, acromegaly & Cushings disease had either prediabetes or diabetes (51% vs 68%, P <0.001 & 51% vs79%, P <0.001) Hypertension was present in 29, 28 & 64% of patients respectively with non-functional tumors, acromegaly and Cushings disease (29% vs 64%, P<0.001). Hypercholesterolemia was present in 48, 32 & 65% of patients respectively with non-functional tumors, acromegaly and Cushings disease (48% vs 65%, P<0.01). The median BMI was 24.8, 26.1 & 29.3 kgs/M2 in patients respectively with non-functional tumors, acromegaly & Cushings disease (24.8 vs 29.3, P<0.41). At follow-up, prediabetes & diabetes resolved in 24, 43 & 50% of patients with non-functional tumors, acromegaly & Cushings disease (24% vs 43%, P<0.01 & 24% vs 50%, P<0.001). Hypertension resolved in 27, 19 & 65% of patients respectively with non-functional tumors, acromegaly & Cushings disease (27% vs 65%, P<0.001). The BMI in patients with acromegaly increased from 26.1 to 28 kgs/M2 (P<0.70).
Conclusions: At follow up, diabetes & hypertension resolved respectively in 50% & 65% of patients with Cushings disease. Diabetes & hypertension resolved respectively in 43% & 19% of patients with acromegaly. Obesity and dyslipidemia persisted in all the sub-groups.